Prof. Dr. Nicholas Andronicos graduated from the University of Wollongong in 2000 with his PhD in Biological Sciences. He undertook his first Postdoctoral Research position (2000-2004) at the Scripps Research Institute in California, USA, where he continued his biomedical research into the blood clotting cascade and the immune system. Once back in Australia, Dr. Andronicos was employed as a Postdoctoral Fellow and Research Scientist at CSIRO Livestock Industries and used molecular cell biology techniques and transcriptomics to examine the sheep immunological responses due to gastrointestinal nematode parasitism. In 2013, Dr. Andronicos joined the University of New England as a lecturer in Biomedical Sciences and is currently employed as an Associate Professor and is responsible for teaching biochemistry, immunology and molecular genetics to science and medicine students. Dr. Andronicos also leads a research group that primarily investigates animal mucosal immunology as well as prototype vaccine development. Other research projects include autoimmunity and the development of synthetic biology solutions to intractable problems.
Prof. Dr. Nicholas Andronicos graduated from the University of Wollongong in 2000 with his PhD in Biological Sciences. He undertook his first Postdoctoral Research position (2000-2004) at the Scripps Research Institute in California, USA, where he continued his biomedical research into the blood clotting cascade and the immune system. Once back in Australia, Dr. Andronicos was employed as a Postdoctoral Fellow and Research Scientist at CSIRO Livestock Industries and used molecular cell biology techniques and transcriptomics to examine the sheep immunological responses due to gastrointestinal nematode parasitism. In 2013, Dr. Andronicos joined the University of New England as a lecturer in Biomedical Sciences and is currently employed as an Associate Professor and is responsible for teaching biochemistry, immunology and molecular genetics to science and medicine students. Dr. Andronicos also leads a research group that primarily investigates animal mucosal immunology as well as prototype vaccine development. Other research projects include autoimmunity and the development of synthetic biology solutions to intractable problems.